Post by PressRelease on Nov 09, 2023 7:01am
New Press Release - Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy
Comment by
Lesalpes29 on Nov 09, 2023 7:05am
OK good one this time! Never too late! Back to mute mode... GLTAL